Edition:
United Kingdom

Corcept Therapeutics Inc (CORT.OQ)

CORT.OQ on NASDAQ Stock Exchange Capital Market

12.17USD
19 Oct 2018
Change (% chg)

$-0.37 (-2.95%)
Prev Close
$12.54
Open
$12.52
Day's High
$12.60
Day's Low
$12.09
Volume
198,952
Avg. Vol
380,548
52-wk High
$25.92
52-wk Low
$11.55

Latest Key Developments (Source: Significant Developments)

Corcept Therapeutics Receives Orphan Designation For Relacorilant As Treatment For Pancreatic Cancer
Monday, 1 Oct 2018 

Oct 1 (Reuters) - Corcept Therapeutics Inc ::CORCEPT THERAPEUTICS RECEIVES ORPHAN DESIGNATION FOR RELACORILANT AS TREATMENT FOR PANCREATIC CANCER.CORCEPT THERAPEUTICS - FDA GRANTED ORPHAN DRUG STATUS TO CORCEPT'S SELECTIVE CORTISOL MODULATOR RELACORILANT TO TREAT PATIENTS WITH PANCREATIC CANCER.  Full Article

Corcept Therapeutics posts Q3 earnings per share $0.11
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Corcept Therapeutics Inc :Corcept Therapeutics announces third quarter 2017 financial results, raises 2017 revenue guidance and provides corporate update.Q3 GAAP earnings per share $0.11.Q3 revenue $42.8 million versus I/B/E/S view $42 million.Q3 earnings per share view $0.14 -- Thomson Reuters I/B/E/S.Sees FY 2017 revenue $157 million to $162 million.  Full Article

BRIEF-FDA Says Making List Of Cos Blocking Access To Samples Of Branded Products

* FDA COMMISSIONER SCOTT GOTTLIEB SAYS MAKING PUBLIC LIST OF COS THAT HAVE POTENTIALLY BEEN BLOCKING ACCESS TO THE SAMPLES OF THEIR BRANDED PRODUCTS